搜尋結果
GSK Faces Whistleblower Suit From Lab That Exposed Zantac Risk
Bloomberg· 8 小時前GSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars ...
Council Post: Medicare Part D In 2024: A Costly Prescription For Retirees?
Forbes· 4 日前Robert Bache (aka "Medicare Bob") is VP of Health at AmeriLife, and Founder of Senior ...
Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone
CNBC· 6 日前Walgreens on Wednesday said it will offer its own cheaper version of the over-the-counter ...
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
CNBC· 6 日前Patients taking Novo Nordisk's obesity drug Wegovy maintained an average of 10% weight loss ...
Watch now: ETF Edge with new funds for a sector that could hit $100B by 2030 - weight loss drugs.
CNBC· 9 小時前[The stream is slated to start at 1:15 PM ET. Please refresh the page if you do not see a player above at that time.]CNBC's ...
Roche shares gain on obesity drug results from early-stage trial
Reuters· 5 日前, opens new tab shares gained as much as 4.7% early on Thursday after an early-stage trial ...
Why China’s top doctor is studying climate change to prepare for next pandemic
South China Morning Post· 4 小時前In 2020, Zhang was appointed leader of Shanghai’s clinical expert team for Covid-19, becoming a ...
Hospital Visits For Cannabis Poisoning Tripled Among Seniors After Canada Legalization, Study Finds
Forbes· 21 小時前The number of older adults hospitalized for cannabis poisoning tripled after Canada legalized ...
India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment
Reuters· 5 日前Indian pharmaceutical company Mankind Pharma posted a more than 65% rise in its fourth-quarter ...
Biogen CEO Looks for Small Deals While Alzheimer’s Drug Ramps Up
Bloomberg· 4 日前Have a confidential tip for our reporters? Biogen Inc.’s Chief Executive Officer is searching ...